FI862978L - Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö. - Google Patents

Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö. Download PDF

Info

Publication number: FI862978L
Authority: FI; Finland
Prior art keywords: oncofetal; preparation; monoclonal antibodies; specific monoclonal; specific
Prior art date: 1984-11-21

Application number

FI862978A

Other languages

English (en)

Swedish (sv)

Other versions

FI92222B (fi

FI862978A0 (fi

FI92222C (fi

Inventor

Jr Joseph H Coggin

Jr William J Payne

Original Assignee

Univ South Alabama

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-11-21

Filing date

1986-07-18

Publication date

1986-07-18

1986-07-18 Application filed by Univ South Alabama filed Critical Univ South Alabama

1986-07-18 Publication of FI862978A0 publication Critical patent/FI862978A0/fi

1986-07-18 Publication of FI862978L publication Critical patent/FI862978L/fi

1994-06-30 Publication of FI92222B publication Critical patent/FI92222B/fi

1994-10-10 Application granted granted Critical

1994-10-10 Publication of FI92222C publication Critical patent/FI92222C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
- G01N2474/20—Immunohistochemistry assay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI862978A 1984-11-21 1986-07-18 Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö. FI92222C (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US06/673,794 US4686180A (en)	1984-11-21	1984-11-21	Onco-fetal specific monoclonal antibodies, methods of preparation and use
US67379484		1984-11-21
US8502258		1985-11-15
PCT/US1985/002258 WO1986003223A1 (en)	1984-11-21	1985-11-15	Onco-fetal specific monoclonal antibodies, methods of preparation and use

Publications (4)

Publication Number	Publication Date
FI862978A0 FI862978A0 (fi)	1986-07-18
FI862978L true FI862978L (fi)	1986-07-18
FI92222B FI92222B (fi)	1994-06-30
FI92222C FI92222C (fi)	1994-10-10

Family

ID=24704144

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI862978A FI92222C (fi)	1984-11-21	1986-07-18	Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.

Country Status (9)

Country	Link
US (1)	US4686180A (fi)
EP (1)	EP0203967B1 (fi)
JP (1)	JPH0683666B2 (fi)
AU (1)	AU593229B2 (fi)
CA (1)	CA1307218C (fi)
DE (1)	DE3583296D1 (fi)
FI (1)	FI92222C (fi)
NO (1)	NO170691C (fi)
WO (1)	WO1986003223A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4675287A (en) *	1984-07-26	1987-06-23	Scripps Clinic And Research Foundation	Monoclonal antibody directed to human ganglioside GD2
FR2571146B1 (fr) *	1984-10-01	1988-02-26	Centre Nat Rech Scient	Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
US5320941A (en) *	1986-06-06	1994-06-14	Dallan Young	DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPH0859089A (ja) *	1994-08-18	1996-03-05	Towa Kogyo Kk	ボビン搬送用トレイ
US20030124125A1 (en) *	1996-04-05	2003-07-03	South Alabama Medical Science Foundation	Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
AU2723597A (en)	1996-04-05	1997-10-29	South Alabama Medical Science Foundation	Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10
DE10346627A1 (de) *	2003-10-08	2005-05-19	Weiss, Stefan, PD Dr.	Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung
GB0510790D0 (en)	2005-05-26	2005-06-29	Syngenta Crop Protection Ag	Anti-CD16 binding molecules
US20070048795A1 (en) *	2005-08-26	2007-03-01	Xiangming Fang	Immunoaffinity separation and analysis compositions and methods
AU2022213913B2 (en)	2021-01-27	2026-01-08	Innovent Biologics (Suzhou) Co., Ltd.	Single-domain antibody against cd16a and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4440863A (en) *	1978-02-22	1984-04-03	Duke University	Breast cyst fluid protein assay
US4272504A (en) *	1978-12-14	1981-06-09	Abbott Laboratories	Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) *	1979-11-21	1982-09-14	The Wistar Institute	Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0072902B1 (de) *	1981-08-21	1985-04-24	F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft	Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
JPH0811075B2 (ja) *	1982-06-30	1996-02-07	雄治松岡	単クローン性抗ｃｅａ抗体

1984
- 1984-11-21 US US06/673,794 patent/US4686180A/en not_active Expired - Lifetime
1985
- 1985-11-15 EP EP85906109A patent/EP0203967B1/en not_active Expired - Lifetime
- 1985-11-15 WO PCT/US1985/002258 patent/WO1986003223A1/en not_active Ceased
- 1985-11-15 AU AU51964/86A patent/AU593229B2/en not_active Ceased
- 1985-11-15 DE DE8585906109T patent/DE3583296D1/de not_active Expired - Lifetime
- 1985-11-15 JP JP60505335A patent/JPH0683666B2/ja not_active Expired - Lifetime
- 1985-11-20 CA CA000495803A patent/CA1307218C/en not_active Expired - Lifetime
1986
- 1986-07-18 NO NO862920A patent/NO170691C/no not_active IP Right Cessation
- 1986-07-18 FI FI862978A patent/FI92222C/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI92222B (fi)	1994-06-30
EP0203967A1 (en)	1986-12-10
AU593229B2 (en)	1990-02-08
FI862978A0 (fi)	1986-07-18
DE3583296D1 (de)	1991-07-25
NO862920D0 (no)	1986-07-18
EP0203967A4 (en)	1987-04-10
NO170691C (no)	1992-11-18
FI92222C (fi)	1994-10-10
NO170691B (no)	1992-08-10
CA1307218C (en)	1992-09-08
EP0203967B1 (en)	1991-06-19
WO1986003223A1 (en)	1986-06-05
JPH0683666B2 (ja)	1994-10-26
JPS62501189A (ja)	1987-05-14
AU5196486A (en)	1986-06-18
US4686180A (en)	1987-08-11
NO862920L (no)	1986-07-18

Publication	Publication Date	Title
FI831234A7 (fi)	1983-10-27	Uudet välituotteet, niiden valmistusmenetelmä ja niiden käyttö.
FI853283A7 (fi)	1986-03-01	Uudet monoklonaaliset glykokonjugaattien vasta-aineet, menetelmät niiden tuottamiseksi, ja niiden käytöt.
NO843293L (no)	1985-02-20	Monoklonale antistoffer, samt fremgangsmaate for fremstilling av slike
DE3885355D1 (de)	1993-12-09	Monoklonale Antikörper.
DE3788148D1 (de)	1993-12-23	Monoklonale Antikörper und deren Verwendung.
FI862978L (fi)	1986-07-18	Onkofetaalisia spesifisiä monoklonaalisia vasta-aineita, menetelmä niiden valmistamiseksi ja niiden käyttö.
FI850515A7 (fi)	1985-08-09	Mikrokiteisiä yhdistelmäräjähdysaineita ja menetelmä niiden valmistamiseksi.
EP0131627A4 (en)	1987-02-26	SPECIFIC ANTIGENS OF THE CEA FAMILY (CARCINO-EMBRYONIC ANTIGEN), SPECIFIC ANTIBODIES OF THESE ANTIGENS AND THEIR METHODS OF USE.
FI823022A7 (fi)	1983-03-04	Amino-organoaminosilaanit, niiden valmistusmenetelmä ja niiden käyttö.
FI850266A7 (fi)	1985-07-24	Atsolyyliaryylialkanolijohdoksia, menetelmä niiden valmistamiseksi ja niiden käyttö.
DK188185A (da)	1985-10-28	Monoklonalt antistof
DE3583341D1 (de)	1991-08-01	Leberwurm-antigene.
DE3780256D1 (de)	1992-08-13	Anti-pci-monoklonaler antikoerper.
DE3586808D1 (de)	1992-12-17	L-thyroxin erkennende monoklonale antikoerper.
FI852647A7 (fi)	1986-01-05	3-aminokarbonyylimetoksi-5 -fenyylipyratsoliyhdisteet ja niiden valmistusmenetelmä sekä näitä yhdisteitä sisältävät lääkeaineet.
IT8422159A0 (it)	1984-08-01	16-fluoro-16,17-dideidro prostanoidi e procedimento per laloro preparazione.
NO851386L (no)	1985-10-07	Fremgangsmaate for fremstilling av antigen.
DK144485A (da)	1985-10-01	Monoklonale antistoffer
DK37785A (da)	1985-07-31	Monoclonalt antistof
FI841410A7 (fi)	1984-10-12	Yhteenliitettyjä filamentteja ja menetelmä niiden valmistamiseksi.
SE468853B (sv)	1993-03-29	Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
NO890116D0 (no)	1989-01-11	Monoklonale antistoffer.
NO873488D0 (no)	1987-08-19	Monoklonale antistoffer.
FI824030A7 (fi)	1983-05-26	Uudet peptidit ja menetelmä niiden valmistamiseksi.
FI894551A7 (fi)	1990-03-28	Hybridiset monoklonaaliset vasta-aineet, niiden valmistus ja käyttö

Legal Events

Date	Code	Title	Description
1994-06-01	BB	Publication of examined application
2004-08-31	MM	Patent lapsed	Owner name: SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION